Clinical Trial Update: Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide [Phase 4]

View source ↗

Summary

Phase 4 trial comparing SMOFlipid and Medialipide in preterm neonates was withdrawn from the study status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Preterm Neonatal Complications

Drugs mentioned

• Medialipide (Medialipide)
• SMOFLIPID

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Preterm Neonates | Phase 4 | Status: WITHDRAWN